# US 2026/0083330 A1 · Method and System for Enhanced Fluorescence Tissue and Cancer Margin Imaging

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083330 A1
- Document ID: US20260083330A1
- Status: Published application
- Kind: A1
- Application number: 18/893,082
- Filed: 2024-09-23
- Published: 2026-03-26
- Earliest claimed: 2023-09-21
- Assignees: CytoVeris, Inc.
- Applicants: CytoVeris Inc.
- Inventors: Alan Kersey; Rishikesh Pandey
- Web page: https://patentgrep.com/patent/US20260083330A1

## CPC

- A61B 5/0071: {by measuring fluorescence emission}
- A61B 5/7267: {involving training the classification device}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method of analyzing a tissue is provided that includes: administering a fluorescent agent to a tissue; producing a first excitation light that is configured to produce a fluorescence emission from the fluorescent agent administered to the tissue; producing a second excitation light that is configured to produce an autofluorescence emission from a biomolecule of interest present within the tissue; using a photodetector to detect the fluorescence emissions and produce first signals representative thereof, and produce second signals representative of the autofluorescence emission; producing an image using the first and second signals. The image includes a first, second and third portions representative of tissue types present within the tissue; and analyzing the tissue to identify diseased tissue and to distinguish it from the first and second tissue types.

## Claims

### Claim 1

A system for analyzing a tissue, comprising:
an excitation light unit configured to selectively produce a plurality of excitation lights, each said excitation light centered on a wavelength distinct from the respective wavelength of the other said excitation lights, wherein the plurality of excitation lights includes a first excitation light configured to produce a fluorescence emission from a fluorescent agent administered to the tissue, and a second excitation light that is configured to produce an autofluorescence emission from a biomolecule of interest present within the tissue;
a photodetector configured to detect the fluorescence emission signal resulting from the first excitation light directed to the tissue and produce first signals representative of the fluorescence emission, and configured to detect the autofluorescence emission signal resulting from the second excitation light directed to the tissue and produce second signals representative of the autofluorescence emission;
a system controller in communication with the excitation light unit, the photodetector, and a non-transitory memory storing instructions, which instructions when executed cause the system controller to:
control the excitation light unit to sequentially produce the first excitation light and the second excitation light;
receive and process the first signals and the second signals to produce an image based on the fluorescence emission and the autofluorescence emission; and
analyze the tissue using the image to identify the presence of a diseased tissue within the tissue, a first type of tissue within the tissue, and a second type of tissue within the tissue, and to distinguish the diseased tissue from the first type of tissue from the second type of tissue.

### Claim 2 (depends on 1)

The system of claim 1, wherein the first type of tissue is healthy tissue and the second type of tissue is healthy tissue.

### Claim 3 (depends on 1)

The system of claim 1, wherein the second excitation light is configured to produce a second autofluorescence emission from the tissue, and the instructions that cause the system controller to analyze the tissue uses the first autofluorescence emission and the second autofluorescence emission.

### Claim 4 (depends on 3)

The system of claim 3, wherein the instructions that cause the system controller to analyze the tissue uses data from known healthy tissues.

### Claim 5 (depends on 4)

The system of claim 4, wherein the instructions that cause the system controller to analyze the tissue uses an artificial intelligence algorithm trained on the known healthy tissues.

### Claim 6 (depends on 1)

The system of claim 1, wherein the first excitation light is configured to produce the fluorescence emission from the fluorescent agent applied to the tissue, and the instructions that cause the system controller to analyze the tissue uses the fluorescence emission from the fluorescent agent applied to the tissue.

### Claim 7 (depends on 6)

The system of claim 6, wherein the instructions that cause the system controller to analyze the tissue uses data from known healthy tissues.

### Claim 8 (depends on 7)

The system of claim 7, wherein the instructions that cause the system controller to analyze the tissue uses an artificial intelligence algorithm trained on the known healthy tissues.

### Claim 9 (depends on 1)

The system of claim 1, wherein the second signals representative of the autofluorescence emission are used to create a map of tissue type in the imaged tissue, and this map is used to correct optical inaccuracies in the first signals representative of the fluorescence emission.

### Claim 10 (depends on 1)

The system of claim 1, wherein the second excitation lights are further configured to produce a diffuse reflectance signal from the tissue, and the photodetector is further configured to detect the diffuse reflectance, and the second signals are representative of the autofluorescence emission and the diffuse reflectance.

### Claim 11

A method of analyzing a tissue, comprising:
administering a fluorescent agent to a tissue;
producing a first excitation light centered on a first wavelength, wherein the first excitation light is configured to produce a fluorescence emission from the fluorescent agent administered to the tissue;
producing a second excitation light centered on a second wavelength, wherein the second excitation light is configured to produce a first autofluorescence emission from one or more biomolecules of interest present within the tissue;
using a photodetector to detect the fluorescence emission and produce first signals representative of the fluorescence emission;
using the photodetector to detect the first autofluorescence emission, and produce second signals representative of the first autofluorescence emission;
producing an image using the first signals and the second signals, wherein the image includes a first portion representative of a first type of tissue present within the tissue, a second portion representative of a second type of tissue present within the tissue, and a third portion representative of a diseased tissue present within the tissue; and
analyzing the tissue using the image to identify a presence of the diseased tissue and to distinguish the diseased tissue from the first type of tissue and the second type of tissue.

### Claim 12 (depends on 11)

The method of claim 11, wherein the step of analyzing the tissue further includes distinguishing the first type of tissue from the second type of tissue.

### Claim 13 (depends on 12)

The method of claim 12, wherein the first type of tissue is healthy tissue and the second type of tissue is healthy tissue.

### Claim 14 (depends on 13)

The method of claim 13, wherein the second excitation light is configured to produce a second autofluorescence emission from the second type of tissue, and the step of distinguishing the first type of tissue from the second type of tissue uses the first autofluorescence emission and the second autofluorescence emission.

### Claim 15 (depends on 14)

The method of claim 14, wherein the analyzing the tissue uses data from known healthy tissues.

### Claim 16 (depends on 15)

The method of claim 15, wherein the step of analyzing the tissue uses an artificial intelligence algorithm trained on the known healthy tissues.

### Claim 17 (depends on 11)

The method of claim 11, wherein the step of analyzing the tissue uses the fluorescence emission from the fluorescent agent applied to the tissue.

### Claim 18 (depends on 11)

The method of claim 11, wherein the second excitation lights are further configured to produce a diffuse reflectance signal from the tissue, and the second signals are representative of the autofluorescence emission and the diffuse reflectance.

### Claim 19

A method of imaging a tissue, comprising:
administering a fluorescent agent to a tissue;
producing a first excitation light centered on a first wavelength, wherein the first excitation light is configured to produce a fluorescence emission from the fluorescent agent administered to the tissue;
producing a second excitation light centered on a second wavelength, wherein the second excitation light is configured to produce an autofluorescence emission from one or more biomolecules of interest present within the tissue;
using a photodetector to detect the fluorescence emission and produce first signals representative of the fluorescence emission;
using the photodetector to detect the autofluorescence emission, and produce second signals representative of the autofluorescence emission;
producing an image of the tissue using the first signals and the second signals, wherein the image includes a first portion representative of a first type of tissue present within the tissue, a second portion representative of a second type of tissue present within the tissue, and a third portion representative of a diseased tissue present within the tissue, and distinguishing the third portion for the first portion and the second portion so that a boundary of the third portion is determinable from the first portion and the second portion.
